David Herrington to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications David Herrington has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.126
-
Mohler ER, Herrington D, Ouyang P, Mangano C, Ritter S, Davis P, Purkayastha D, Gatlin M, Vogel RA. A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood pressure. J Clin Hypertens (Greenwich). 2006 Oct; 8(10):692-8.
Score: 0.066
-
Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens. 2005 Jul; 23(7):1311-25.
Score: 0.060